Intravitreal Aflibercept Injection vs Sham as Prophylaxis Against Conversion to Exudative Age-Related Macular Degeneration in High-risk Eyes-Reference-Cited by-同舟云学术

Intravitreal Aflibercept Injection vs Sham as Prophylaxis Against Conversion to Exudative Age-Related Macular Degeneration in High-risk Eyes

Published:2021-05-01 Issue:5 Volume:139 Page:542
ISSN:2168-6165
Container-title:JAMA Ophthalmology
language:en
Short-container-title:JAMA Ophthalmol

Author:

Heier Jeffrey S.¹,Brown David M.²,Shah Sumit P.³,Saroj Namrata⁴,Dang Sabin⁵,Waheed Nadia K.⁶,Wykoff Charles C.⁷,Prenner Jonathan L.⁸,Boyer David S.⁹

Affiliation:

1. Ophthalmic Consultants of Boston, Boston, Massachusetts

2. Retina Consultants of Houston, Houston, Texas

3. New Jersey Retina, New Brunswick, New Jersey

4. All Eyes Consulting, LLC, New York, New York

5. The Retina Institute, St Louis, Missouri

6. Boston Image Reading Center, Tufts Medical Center, Boston, Massachusetts

7. Retina Consultants of Houston, Retina Consultants of America, Blanton Eye Institute, Houston Methodist Hospital, Weill Cornell Medical College, Houston, Texas

8. Department of Ophthalmology, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey

9. Retina Vitreous Associates Medical Group, Los Angeles, California

Publisher

American Medical Association (AMA)

Subject

Ophthalmology

Link

https://jamanetwork.com/journals/jamaophthalmology/articlepdf/2777577/jamaophthalmology_heier_2021_oi_210008_1620914796.36303.pdf

Reference12 articles.

1. Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS): AREDS report No. 19.;Clemons;Ophthalmology,2005

2. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report No. 8.;Age-Related Eye Disease Study Research Group;Arch Ophthalmol,2001

3. Incidence of choroidal neovascularization in the fellow eye in the comparison of age-related macular degeneration treatments trials.;Maguire;Ophthalmology,2013

4. Incidence of new choroidal neovascularization in fellow eyes of patients treated in the MARINA and ANCHOR trials.;Barbazetto;Am J Ophthalmol,2010

5. Incidence of new choroidal neovascularization in fellow eyes of patients with age-related macular degeneration treated with intravitreal aflibercept or ranibizumab.;Parikh;JAMA Ophthalmol,2019

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-VEGF Treatment for Secondary Neovascularization in Pseudoxanthoma Elasticum - Age of Onset, Treatment Frequency, and Visual Outcome;American Journal of Ophthalmology;2024-09

2. Non-exudative choroidal and macular neovascularizations: An overview;European Journal of Ophthalmology;2024-08-14

3. Comparison between indocyanine green angiography and optical coherence tomography angiography for the detection of nonexudative macular neovascularization;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-07-27

4. Anti-angiogenic biomolecules in neovascular age-related macular degeneration; therapeutics and drug delivery systems;International Journal of Pharmaceutics;2024-06

5. American Society of Retina Specialists Clinical Practice Guidelines on Multimodal Imaging for Retinal Disease;Journal of VitreoRetinal Diseases;2024-03-21